Rockefeller Capital Management
ADMS

Rockefeller Capital Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Rockefeller Capital Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,576
Closed -$17K – 4116
2021
Q3 		$17K Hold
3,576
– – ﹤0.01% 2672
2021
Q2 		$18K Buy
+3,576
New +$18.5K ﹤0.01% 2539

Rockefeller Capital Management's ADMS Position: Q4 2021 in Review

Rockefeller Capital Management sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 3,576 shares — an estimated $17K sold.

Rockefeller Capital Management first reported a position in ADMS in Q2 2021 and held it in 2 quarters. The position peaked at $18K in Q2 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

  • Rockefeller Capital Management reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 3,576 Adamas Pharmaceuticals shares in Q4 2021, an estimated $17K.
  • Rockefeller Capital Management first reported a position in Adamas Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Rockefeller Capital Management's Adamas Pharmaceuticals position peaked at $18K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Rockefeller Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.